Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 11/20 | 0.56 |
| ▸ | CD40 | P25942 | 1/20 | 0.49 |
| ▸ | CD40LG | P29965 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14773653 | 0.92 | ENPP2 (0.57) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL19958155 | 0.91 | ENPP2 (0.62) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL15935810 | 0.90 | ENPP2 (0.57) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL15935814 | 0.89 | ENPP2 (0.58) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL15935812 | 0.89 | ENPP2 (0.55) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL17460958 | 0.88 | ENPP2 (0.56) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL14773825 | 0.88 | ENPP2 (0.57) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL17284065 | 0.88 | ENPP2 (0.53) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL14773827 | 0.88 | ENPP2 (0.57) | ENPP2CD40CD40LGALDH1A1HIF1A | |
| SCHEMBL17460970 | 0.87 | ENPP2 (0.55) | ENPP2CD40CD40LGALDH1A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160103362-A1 | Azo Compound and Salt Thereof, And Dye-Based Polarizing Film And Polarizing Plate Containing The Same | POLATECHNO CO LTD (JP) | 2016-04-14 | — | — | US | disclosed |
| US-9244194-B2 | Azo compound and salt thereof, and dye-based polarizing film and polarizing plate containing the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160103362-A1 | Azo Compound and Salt Thereof, And Dye-Based Polarizing Film And Polarizing Plate Containing The Same | TYR, CRY1, NAP1L4 | ENPP2 2889/4885CD40 4579/4885CD40LG 4231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.